We are live on ! Find out more
CCG

Cypress Capital Group Portfolio holdings

AUM $889M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+27.23%
3 Year Est. Return
+83.89%
5 Year Est. Return
+113.23%
10 Year Est. Return
+324.61%
AUM
$890M
AUM Growth
+$55.4M
Cap. Flow
+$1.26M
Cap. Flow %
0.14%
Top 10 Hldgs %
33.32%
Holding
322
New
28
Increased
107
Reduced
160
Closed
12

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.27M
2
VZ icon
Verizon
VZ
+$1.21M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.14M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$964K
5
TXT icon
Textron
TXT
+$867K

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Healthcare 16.44%
3 Financials 10.2%
4 Consumer Discretionary 8.09%
5 Industrials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
101
Stryker
SYK
$135B
$1.68M 0.19%
4,653
SUB icon
102
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$1.62M 0.18%
15,296
+1,415
+10% +$149K
AGG icon
103
iShares Core US Aggregate Bond ETF
AGG
$138B
$1.61M 0.18%
15,883
+302
+2% +$30.1K
SNA icon
104
Snap-on
SNA
$21.5B
$1.59M 0.18%
5,501
-222
-4% -$61.2K
MCO icon
105
Moody's
MCO
$83.7B
$1.58M 0.18%
3,325
+8
+0.2% +$3.71K
MCK icon
106
McKesson
MCK
$104B
$1.58M 0.18%
3,187
-139
-4% -$77.4K
IWB icon
107
iShares Russell 1000 ETF
IWB
$47.1B
$1.55M 0.17%
4,918
-11
-0.2% -$3.33K
CAH icon
108
Cardinal Health
CAH
$53.7B
$1.46M 0.16%
13,213
-617
-4% -$64.5K
SOLV icon
109
Solventum
SOLV
$15.3B
$1.44M 0.16%
20,706
+1,719
+9% +$103K
DHR icon
110
Danaher
DHR
$138B
$1.37M 0.15%
4,924
+39
+0.8% +$10.3K
IJH icon
111
iShares Core S&P Mid-Cap ETF
IJH
$121B
$1.36M 0.15%
21,829
-1,069
-5% -$64.5K
LMBS icon
112
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
$1.33M 0.15%
26,901
+1,925
+8% +$94.2K
RL icon
113
Ralph Lauren
RL
$22.4B
$1.29M 0.15%
6,653
+3,029
+84% +$524K
LEN icon
114
Lennar Class A
LEN
$20.4B
$1.28M 0.14%
7,051
-888
-11% -$149K
T icon
115
AT&T
T
$164B
$1.28M 0.14%
58,060
+922
+2% +$18.3K
IWM icon
116
iShares Russell 2000 ETF
IWM
$79.1B
$1.27M 0.14%
5,772
-1
-0% -$214
SBAC icon
117
SBA Communications
SBAC
$19.8B
$1.24M 0.14%
5,166
-8
-0.2% -$1.77K
SLB icon
118
SLB Ltd
SLB
$72.7B
$1.24M 0.14%
29,541
+1,264
+4% +$56.3K
CMCSA icon
119
Comcast
CMCSA
$87.3B
$1.23M 0.14%
29,363
-546
-2% -$21.6K
EMR icon
120
Emerson Electric
EMR
$81.6B
$1.21M 0.14%
11,056
-11
-0.1% -$1.18K
SWK icon
121
Stanley Black & Decker
SWK
$14.5B
$1.2M 0.13%
10,872
-71
-0.6% -$6.82K
PNC icon
122
PNC Financial Services
PNC
$99.1B
$1.18M 0.13%
6,390
-21
-0.3% -$3.68K
SLV icon
123
iShares Silver Trust
SLV
$27.7B
$1.17M 0.13%
41,154
+32,385
+369% +$870K
PHM icon
124
Pultegroup
PHM
$25.2B
$1.17M 0.13%
8,140
-123
-1% -$15.6K
BKNG icon
125
Booking.com
BKNG
$156B
$1.17M 0.13%
6,925
+25
+0.4% +$3.83K

Similar funds

Cypress Capital Group's Q3 2024 Portfolio in Review

As of Q3 2024, Cypress Capital Group held 322 positions worth $890M, up 6.6% from $834M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cypress Capital Group's Q3 2024 filing shows 28 new, 107 increased, 160 reduced and 12 closed positions. Its largest new stake was Advanced Micro Devices: 10,380 shares worth $1.7M. The largest sale was Eli Lilly, an estimated $1.27M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Cypress Capital Group's largest Q3 2024 buy was Advanced Micro Devices: 10,380 shares worth $1.7M.
  • Cypress Capital Group added most to Broadcom in Q3 2024, an estimated $1.37M increase.
  • Cypress Capital Group's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.27M.
  • Cypress Capital Group fully exited Textron in Q3 2024, selling an estimated $867K.
  • Cypress Capital Group's ten largest holdings make up 33% of its $890M portfolio in Q3 2024.
  • Cypress Capital Group opened 28 new positions and closed 12 in Q3 2024.
  • Cypress Capital Group's portfolio value rose 6.6% quarter-over-quarter to $890M.

Based on Cypress Capital Group's 13F filing for Q3 2024, filed 8 Nov 2024.